Original Research
Published on 22 Nov 2021
LuHui Derivative, A Novel Compound That Inhibits the Fat Mass and Obesity-Associated (FTO), Alleviates the Inflammatory Response and Injury in Hyperlipidemia-Induced Cardiomyopathy
in Epigenomics and Epigenetics
- 5,531 views
- 24 citations